{
    "clinical_study": {
        "@rank": "149569", 
        "arm_group": [
            {
                "arm_group_label": "Bronchoscopy guided by fluoroscopy", 
                "arm_group_type": "Other", 
                "description": "Bronchoscopy guided by fluoroscopy followed by ENG"
            }, 
            {
                "arm_group_label": "Bronchoscopy guided by electromagnetic navigation", 
                "arm_group_type": "Experimental", 
                "description": "Bronchoscopy guided by ENG followed by fluoroscopy"
            }
        ], 
        "brief_summary": {
            "textblock": "Due to CT screening, a lot of peripheral nodule not accessible to conventional endoscopy\n      will be found. Electromagnetic navigation directed bronchoscopy (ENB) is a new technique\n      needing validation. the primary aim of the study is to compare ENB to radiologically guided\n      bronchoscopy, considered the standard comparator."
        }, 
        "brief_title": "Bronchoscopy Assisted by Electromagnetic Navigation (EMN) in the Diagnosis of Small Pulmonary Nodules", 
        "completion_date": {
            "#text": "December 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Pulmonary Nodule Cm", 
        "condition_browse": {
            "mesh_term": "Lung Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Presence on a conventional or low dose chest CT at least one lung nodule 5-20 mm in\n             its largest axis, of indeterminate nature; the nodule must be positive at PET-CT\n             examination (in case of PET-CT negative, only follow-up is proposed)\n\n          -  The pulmonary nodule(s) must be known for less than 6 months\n\n          -  The nodule appearance can be solid, presents as a ground glass opacity with solid\n             component or as pure ground glass opacity\n\n          -  Availability for participating in the detailed follow-up of the protocol\n\n          -  Signed informed consent.\n\n          -  Age > 18 years\n\n        Exclusion Criteria:\n\n          -  Nodules found in the context of an active infection or for whom, the clinical context\n             and/or additional available investigations (serology, microbiological samplings,\n             immune abnormalities) show that cancer diagnosis is unlikely\n\n          -  Nodules found in the context of an active previously documented disease that can be\n             associated with pulmonary nodules (anthracosilicosis, histoplasmosis, tuberculosis,\n             autoimmune or rheumatoid diseases \u2026)\n\n          -  Calcified nodule\n\n          -  Anticoagulation therapy of any type that cannot be suspended for the duration of the\n             investigation\n\n          -  Respiratory failure, recent myocardial infarction (less than 3 months prior to the\n             date of lung nodule screening), uncontrolled angina pectoris, congestive cardiac\n             failure, cardiac arrhythmia, uncontrolled infectious disease or any other physical,\n             biological or psychological factor which may prevent adherence to the study protocol\n             or which may impair the patient's tolerance to the endoscopy and/or the general\n             anaesthesia\n\n          -  Presence of a implanted cardiac device (pace-maker, defibrillator, \u2026)\n\n          -  Pregnant women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01779388", 
            "org_study_id": "01201"
        }, 
        "intervention": {
            "arm_group_label": [
                "Bronchoscopy guided by fluoroscopy", 
                "Bronchoscopy guided by electromagnetic navigation"
            ], 
            "description": "During a general anaesthesia, an evaluation will be done by conventional bronchoscopy guided by fluoroscopy and by bronchial endoscopy guided by electromagnetic navigation, the selection of order in techniques being randomly assigned.", 
            "intervention_name": "Bronchoscopy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lung nodule", 
            "PET scanner", 
            "Bronchoscopy", 
            "Electromagnetic navigation"
        ], 
        "lastchanged_date": "January 29, 2013", 
        "link": {
            "description": "ELCWP site", 
            "url": "http://www.elcwp.org"
        }, 
        "location": {
            "contact": {
                "email": "nathalie.leclercq@bordet.be", 
                "last_name": "Nathalie Leclercq, RN", 
                "phone": "003225413192"
            }, 
            "facility": {
                "address": {
                    "city": "Brussels", 
                    "country": "Belgium", 
                    "zip": "1000"
                }, 
                "name": "Institut Jules Bordet"
            }, 
            "investigator": {
                "last_name": "Thierry Berghmans, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "Role of Bronchoscopy Assisted by Electromagnetic Navigation (EMN) in the Diagnosis of Small Pulmonary Nodules of Indeterminate Nature. A Prospective Study by the European Lung Cancer Working Party.", 
        "overall_contact": {
            "last_name": "Thierry Berghmans, MD, PhD", 
            "phone": "003225413191"
        }, 
        "overall_contact_backup": {
            "email": "nathalie.leclercq@bordet.be", 
            "last_name": "Nathalie Leclercq, RN", 
            "phone": "003225413192"
        }, 
        "overall_official": [
            {
                "affiliation": "ELCWP", 
                "last_name": "Thierry Berghmans, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "ELCWP", 
                "last_name": "Dimitri Leduc, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Federal Agency for Medicinal Products and Health Products", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Calculate the sensitivity of each endoscopic technique in obtaining the diagnostic of the pulmonary nodule", 
            "measure": "Capability of diagnosing lung nodule with ENB (Sensitivity)", 
            "safety_issue": "Yes", 
            "time_frame": "After the procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01779388"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "To identify a predictive molecular signature able to predict the malignant nature of the nodule by studying the transcriptome (miRNAs and mRNAs) and the single nucleotide polymorphism (SNPs) by using high throughput techniques in biopsies, alveolar lavage, blood and exhaled breath", 
            "measure": "Prediction of malignancy", 
            "safety_issue": "No", 
            "time_frame": "After the procedure"
        }, 
        "source": "European Lung Cancer Working Party", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Lung Cancer Working Party", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}